Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
47 hedge funds and large institutions have $219M invested in Taro Pharmaceutical Industries Ltd. in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 4 closing their positions.
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
62% more capital invested
Capital invested by funds: $136M → $219M (+$83.5M)
38% more funds holding
Funds holding: 34 → 47 (+13)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$28.5M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$8.17M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$5.03M |
| 4 |
Renaissance Technologies
New York
|
+$3.24M |
| 5 |
MCP
Moab Capital Partners
Southampton,
New York
|
+$2.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$14.7M |
| 2 |
AA
Ancient Art
Austin,
Texas
|
-$4.92M |
| 3 |
Two Sigma Investments
New York
|
-$568K |
| 4 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
-$391K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$267K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| – | -$148K | -2,645 | Closed |
|
TARO Hedge Fund Activity: Q3 2013 in Review
47 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2013, worth a combined $219M — up 62% from $136M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new TARO positions and 4 closed out — a net gain of 13 holders — while 11 added to existing stakes and 13 trimmed.
The largest buyer was Hotchkis & Wiley Capital Management, opening a new position worth an estimated $28.5M. The largest seller was Raging Capital Management, cutting an estimated $14.7M.
- 47 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2013, up from 34 in Q2 2013.
- Funds reported $219M of Taro Pharmaceutical Industries Ltd. stock for Q3 2013, up 62% quarter-over-quarter.
- 17 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2013 and 4 closed out, a net change of +13 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2013 was Hotchkis & Wiley Capital Management, an estimated $28.5M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2013 was Raging Capital Management, an estimated $14.7M sold.
Based on aggregated 13F filings for Q3 2013.